Medicare Enrolled
Dr. Michael De Luca, MD
Cardiovascular Disease · El Paso, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. De Luca from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. De Luca?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. De Luca
Dr. Michael De Luca is a cardiovascular disease specialist in El Paso, TX, with 21 years of NPI registration. Based on federal Medicare data, Dr. De Luca performed 7,536 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. De Luca received a total of $22,854 from 30 pharmaceutical and/or device companies across 534 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. De Luca is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 7% volume in TX
$22,854 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗7,536
Medicare services
Top 7% in TX for cardiovascular disease
Not available
Unique patients (not deduplicated)
$91
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
2,539 | $0 | $0 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,441 | $85 | $309 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
647 | $40 | $232 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
474 | $10 | $48 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
277 | $129 | $642 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
192 | $50 | $216 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
156 | $29 | $119 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 152 | $975 | $3,823 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
139 | $36 | $147 |
| Injection, fentanyl citrate, 0.1 mg | 129 | $1 | $2 |
| Midazolam injection, per 1 mg Administration of midazolam hydrochloride, a sedative medication, measured in 1 mg increments. |
121 | $0 | $0 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
114 | $36 | $181 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle while at rest and during stress. |
112 | $1,016 | $3,942 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
83 | $62 | $209 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
78 | $86 | $304 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
75 | $29 | $147 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
73 | $14 | $57 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
72 | $18 | $79 |
| New patient office visit, complex (60-74 min) | 66 | $155 | $595 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
57 | $25 | $71 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
53 | $126 | $593 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
50 | $51 | $168 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
38 | $19 | $79 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
38 | $621 | $2,031 |
| Nuclear stress test with CT scan A nuclear medicine imaging test that evaluates blood flow in the heart muscle at rest and during stress, performed alongside a concurrent CT scan. |
37 | $1,723 | $9,180 |
| PET scan of heart muscle blood flow A nuclear medicine imaging test that uses positron emission tomography (PET) to evaluate blood flow within the heart muscle. |
36 | $133 | $691 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
36 | $87 | $700 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
35 | $314 | $1,351 |
| Cardiac catheterization | 33 | $732 | $3,018 |
| Continuous ECG monitoring with transmission and review Continuous electrocardiogram monitoring for up to 30 days with symptom tracking. The data is transmitted and reviewed by a healthcare professional who provides a report. |
30 | $18 | $75 |
| Additional sedation, per 15 minutes Administration of a drug to deepen sedation during a procedure. This code covers each additional 15-minute increment of sedation beyond the initial period. |
24 | $8 | $31 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
19 | $112 | $477 |
| Ultrasound-guided injection into a single leg vein A chemical agent is injected into one incompetent vein in the leg while using ultrasound to guide the needle placement. |
18 | $980 | $4,029 |
| Ultrasound of heart blood vessel or graft An ultrasound exam to evaluate blood flow in a heart blood vessel or graft, including a radiologist's review of the initial vessel. |
17 | $66 | $265 |
| Cardiac rhythm monitor evaluation Review and analysis of data recorded by a cardiac rhythm monitoring device to assess heart activity. |
16 | $31 | $104 |
| Ultrasound of arm and leg arteries This procedure uses sound waves to create images of the blood vessels in the arms and legs. It allows healthcare providers to examine the structure and blood flow within these arteries. |
16 | $41 | $248 |
| Radiofrequency vein destruction, first vein A procedure to treat the first incompetent vein in the arm or leg using radiofrequency energy and imaging guidance. |
15 | $788 | $4,716 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
15 | $42 | $120 |
| Coronary stent placement A procedure to insert a stent into a coronary artery or its branch to keep it open, using balloon dilation during the process. |
13 | $396 | $1,789 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
4.9% high complexity
51.7% medium
43.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$22,854
Total received (2018-2024)
Avg $3,265/year across 7 years
Top 17% in TX for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
30
Companies
534
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$577
2023
$1,010
2022
$1,028
2021
$2,187
2020
$2,177
2019
$12,827
2018
$3,048
Payments by company (2024)
Boston Scientific Corporation
$253
PFIZER INC.
$93
E.R. Squibb & Sons, L.L.C.
$37
Novartis Pharmaceuticals Corporation
$32
Amgen Inc.
$30
W. L. Gore & Associates, Inc.
$23
Actelion Pharmaceuticals US, Inc.
$22
Medtronic, Inc.
$21
Boehringer Ingelheim Pharmaceuticals, Inc.
$19
Janssen Pharmaceuticals, Inc
$19
AstraZeneca Pharmaceuticals LP
$15
CORDIS US CORP.
$15
Top 3 companies account for 66.2% of 2024 payments
All-time payments by company (2018-2024) ›
BARD PERIPHERAL VASCULAR, INC.
$5,793
Bard Peripheral Vascular, Inc.
$5,557
Abbott Laboratories
$4,129
Janssen Pharmaceuticals, Inc
$1,059
Boston Scientific Corporation
$876
AstraZeneca Pharmaceuticals LP
$782
Medtronic, Inc.
$734
E.R. Squibb & Sons, L.L.C.
$698
Amgen Inc.
$633
Novartis Pharmaceuticals Corporation
$558
PFIZER INC.
$383
Terumo Medical Corporation
$327
Medtronic Vascular, Inc.
$299
Boehringer Ingelheim Pharmaceuticals, Inc.
$266
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$192
Philips Electronics North America Corporation
$162
Merck Sharp & Dohme LLC
$58
Ra Medical Systems, Inc.
$41
ABIOMED
$34
Gilead Sciences, Inc.
$34
CORDIS US CORP.
$34
Amarin Pharma Inc.
$33
BOSTON SCIENTIFIC CORPORATION
$32
Tactile Systems Technology Inc
$27
Impulse Dynamics (USA) Inc.
$24
W. L. Gore & Associates, Inc.
$23
Actelion Pharmaceuticals US, Inc.
$22
HeartFlow, Inc.
$20
Chiesi USA, Inc.
$13
Kowa Pharmaceuticals America, Inc.
$12
Top 3 companies account for 67.7% of all-time payments
Associated products mentioned in payments ›
(5139) IGT Fixed SV TnM · (9266) ELCA · AVVIGO Guidance System · Allure CRT Pacemaker · Allure Quadra RF CRT Pacemaker · Assurity Pacemaker · BRILINTA · CAMZYOS · CHANTIX · CRT Leads · CRT-Ds · CardioMEMS HF System · Confirm Rx · Corlanor · DABRA · Durata Defibrillation ICD Lead · ELIQUIS · EMBLEM MRI S-ICD · ENDURANT IIS · ENTRESTO · Ellipse ICD · FARXIGA · FFRct · Flexitouch Plus · Fortify Assura · GORE VIABAHN VBX Balloon Expandable Endo · General - Vascular Intervention · GlideWire · Glidesheath · Guidezilla · HARMONY · HawkOne · HeartMate 3 Left Ventricular Dev · IGT D Peripheral · IN.PACT Admiral · INGEVITY MRI · INGEVITY+ · Image Guided Therapy Devices _ Coronary · Impella · JARDIANCE · KENGREAL · LATITUDE Communicator Power Supply · LEQVIO · LIFESTENT · LIFESTREAM · LINQ II · LUTONIX · LUX-Dx Insertable Cardiac Monitor · LifeVest · Livalo · MAMBA · MRI Ready Leads · Merlin Connectivity and Remote · Navicross · ONYX FRONTIER · OPTIMIZER · OptiSense Pacing Lead · Optisure Defibrillation ICD Lead · Quadra Allure MP RF CRT Pacemkr · Quadra Assura CRT Defibrillator · Quartet CRT Lead · RAIDEN3T · RAIN SHEATH · RESOLUTE ONYX · ROTABLATOR · ROTAPRO · Repatha · Resolute · Reveal LINQ · RotaWire and wireClip Torquer · Rotablator Rotational Atherectomy System Console Kit · SYNERGY · Stellarex · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TR Band · UPTRAVI · Unify Assura CRT Defibrillator · VENASEAL · VENOVO · VERQUVO · VYNDAQEL · Vascepa · Venovo · WATCHMAN · XARELTO · Xience Sierra Coronary Stent · Xience Sierra Coronary Stent System · myLUX Patient Kit with mobile device
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Cardiologists in nearby ZIP areas
34
County median income
$58,859
Nearest hospital to ZIP centroid (approximate)
RIO VISTA BEHAVIORAL HEALTH
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. De Luca is a clinical cardiology specialist, with above-average Medicare volume (top 7% in TX), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. De Luca experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. De Luca performed 2,539 contrast dye for imaging (iodine-based) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. De Luca receive payments from pharmaceutical companies?
Yes. Dr. De Luca received a total of $22,854 from 30 companies across 534 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. De Luca's costs compare to other cardiologists in El Paso?
Dr. De Luca's average Medicare payment per service is $91. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. De Luca) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in El Paso
Browse cardiologists in El Paso ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in TX
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in TX
Which TX cardiologists receive the most from drug and device companies.
By company
BARD PERIPHERAL VASCULAR, INC. Payments to Doctors
See all physicians who received payments from BARD PERIPHERAL VASCULAR, INC.
By company
Bard Peripheral Vascular, Inc. Payments to Doctors
See all physicians who received payments from Bard Peripheral Vascular, Inc.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology